Rare disease research and CNS tumors
Unlock the power of epigenetics in precision medicine research. In this webinar, Bekim Sadikovic and Helge Lubenow demonstrate how methylation signatures and 5-base sequencing are accelerating rare disease research, clarifying ambiguous results, and improving tumor classification.